Location History:
- San Rafael, CA (US) (1997 - 2001)
- Saan Rafael, CA (US) (2001 - 2003)
Company Filing History:
6 out of 15,471 
1 out of 19 
2 out of 832,812 Years Active: 1997-2003
Title: Kenneth R Feingold: Pioneering Innovator in Disrupting Epithelial Barrier Function
Introduction:
Kenneth R Feingold, a distinguished inventor based in San Rafael, CA, has made significant contributions in the field of disrupting epithelial barrier function through innovative methods and compositions. With a total of 8 patents to his name, Feingold has demonstrated unparalleled expertise in this specialized domain.
Latest Patents:
Feingold's most recent patents revolve around methods and compositions for disrupting the epithelial barrier function. These patents entail a groundbreaking approach that involves applying barrier-disrupting agents to the epithelium of the host, thereby facilitating the topical administration of physiologically active substances. The patents encompass a diverse array of inhibitors and enzymes that target ceramide, acylceramide, glucosylceramide, sphingomyelin, fatty acids, and cholesterol synthesis, showcasing Feingold's innovative thinking and problem-solving skills.
Career Highlights:
During his illustrious career, Kenneth R Feingold has been associated with reputable institutions such as the University of California, where he has undoubtedly left a lasting impact through his pioneering research and inventions. His relentless pursuit of excellence and commitment to advancing scientific knowledge have earned him recognition as a trailblazer in the field of disrupting epithelial barrier function.
Collaborations:
Feingold's collaborative efforts have been instrumental in shaping the landscape of his research area. Working alongside esteemed colleagues such as Peter Michael Elias and Karen Hanley, he has fostered a culture of innovation and shared expertise, leading to groundbreaking discoveries and advancements in the field. These fruitful collaborations underscore Feingold's ability to work cohesively within multidisciplinary teams, further enhancing his reputation as a visionary inventor.
Conclusion:
In conclusion, Kenneth R Feingold stands out as a visionary innovator whose groundbreaking work in disrupting epithelial barrier function has paved the way for transformative advancements in the field. With a prolific patent portfolio and a stellar career marked by notable collaborations, Feingold continues to inspire and push the boundaries of scientific exploration. His contributions undoubtedly underscore the indispensable role of inventors in driving innovation and progress in the realm of medical research and beyond.